Drugs Made In America Acquisition Corp. Rights
Price
Key statistics
- Forward rate
- $0.00
- Yield
- 0.00%
- Payout ratio
- 0.00%
- Frequency
- Unknown
Drugs Made In America Acquisition Corp. Rights is a rights security linked to Drugs Made In America Acquisition Corp., a special purpose acquisition company focused on completing a business combination in the pharmaceutical and healthcare-related sectors. Each right represents a contractual entitlement to receive a fraction of an ordinary share when a qualifying combination is completed, making it part of the company’s capital structure rather than an operating business on its own. The security is designed for investors who hold the company’s units and may be separated for separate trading after issuance. Drugs Made In America Acquisition Corp. uses this rights instrument to support its acquisition-focused model, which centers on identifying and combining with businesses connected to drug manufacturing, life sciences, and related healthcare markets. As a SPAC-related security, it plays a financing and transaction-support role within the broader public markets.
- CEO
- Ms. Lynn Stockwell
- Headquarters
- New York, NY, United States
- Website
- dmaacorp.com